Загрузка...
Releasing the Brake on the Immune System: Ipilimumab in Melanoma and Other Tumors
Advanced melanoma has proven difficult to treat for many years, and no previous agent has shown improved survival in a phase 3 trial. The deepening understanding of tumor immunobiology and the complexity of the interactions between host T cells and cancer have led to novel treatment approaches. Amon...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Mary Ann Liebert, Inc.
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3011989/ https://ncbi.nlm.nih.gov/pubmed/21204754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2010.0865 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|